Mehreen Sarwar
Doctor member of the Royal College of Obstetricians & Gynecologists Zia Medical Center and Prime Hospital , London UK
Title: Nonsurgical Vulvovaginal Rejuvenation with Radiofrequency for GSM
Biography
Biography: Mehreen Sarwar
Abstract
Many medical disciplines, including dermatologists, cosmetic and reconstructive surgeons, urologists, and gynecologists, are interested in Nonsurgical Vulvovaginal Rejuvenation (NVR). There is evidence that supports energy-based, minimally invasive devices like radiofrequency are beneficial at tightening the vagina and reducing symptoms of vulvovaginal atrophy (VVA) and/or the genitourinary syndrome of menopause (GSM). Vaginal dryness (VD), vaginal laxity (VL), pain during sexual activity (SAPain), vaginal itching (VI), burning, pain, and symptoms in the urinary organs are all aspects of the genitourinary syndrome of menopause (GSM). A thorough history, examination, and discussion of goals of treatment can help identify suitable candidates for NVR. Patients with GSM report symptoms of laxity, dryness, itching, urinary incontinence, and even pain. These patients tend to be menopausal women, though GSM can occur at any age. Patients with VL will report experiencing vaginal laxity during intercourse and largely remains a self-reported condition. They are often premenopausal women with a history of vaginal childbirth. With the contraindications and limitations of standard therapy for GSM Non-ablative radiofrequency (RF) has emerged as a new alternative technique for GSM. It is a high-frequency current used for therapeutic purposes, based on the mechanism of heat production by conversion, that is, ionic and molecular mobilization, favoring oxygenation, nutrition, and vasodilation of tissues. The heating of the tissues also promotes the denaturation of collagen with a subsequent contraction of its fibers, retraction of fibrous septa, and activation of fibroblasts. Neocolagenization, neoelastogenesis, and reorganization of collagen fibers may occur, resulting in tissue remodeling. Intravaginal RF reduced the clinical symptoms of GSM in most patients, especially during T1, and women reported satisfaction with treatment. The technique showed no adverse effects, and there were positive therapeutic benefits on sexual disfunction and stress incontinence.